Introduction Concurrent prescribing of opioids and benzodiazepines is associated with
increased risk of emergency department visits and overdose. Postpartum women commonly …

Importance The COVID-19 pandemic substantially disrupted routine health care and
exacerbated existing barriers to health care access. Although postpartum women frequently …

Opioid and benzodiazepine prescribing after COVID‐19 hospitalization is not well
understood. We aimed to characterize opioid and benzodiazepine prescribing among naïve …

Background Healthcare access has changed drastically during the COVID-19 pandemic.
Elective medical procedures, including routine office visits, were restricted raising concerns …

Methods A retrospective review of acute care presentations of patients with concomitant
pregnancy (Z33. 1) and opioid-related diagnostic codes (T10 codes and/or F11) was …

Background COVID-19 and resulting mitigation measures in the United States (US) brought
about limited access to medical care that has been linked to increases in mental health …

Importance The COVID-19 pandemic disrupted medical care, impacting prescribing of
opioid analgesics and buprenorphine for opioid use disorder. Understanding these patterns …

Opioids and benzodiazepines are two of the leading causes of adverse drug events (ADEs),
both during hospitalization and in the posthospitalization period. 1, 2 While they have clear …

Objectives Pregnancy provides a critical opportunity to engage individuals with opioid use
disorder in care. However, before the COVID-19 pandemic, there were multiple barriers to …

Purpose Postpartum mood disorders affect many women following childbirth. Prescribing
medication for depression and anxiety is one strategy for the effective treatment of …